American Academy of Family Physicians

Printer-friendly version

Share this on AAFP Connection

Share this page

March 2007

FDA News

FDA Requests Withdrawal

Novartis Pulls Zelnorm From U.S. Market

(3/30/2007, 3:30 p.m.)  --  Earlier today, FDA officials issued a public health advisory announcing that Novartis Pharmaceuticals Corp. has complied with an FDA request to immediately cease all U.S. sales and marketing of its prescription drug tegaserod maleate, sold as Zelnorm. More


Shop Catalog